Histidine-rich calcium binding protein: The new regulator of sarcoplasmic reticulum calcium cycling

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 43-49

  Arvanitis, Demetrios A ^a   Vafiadaki, Elizabeth ^a   Sanoudou, Despina ^a,b   Kranias, Evangelia G ^a,c  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Arrhythmia; Calcium homeostasis; Contractility; Heart failure; HRC

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM ION; HISTIDINE RICH CALCIUM BINDING PROTEIN; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CONGESTIVE CARDIOMYOPATHY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; SARCOPLASMIC RETICULUM;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CALCIUM-BINDING PROTEINS; HUMANS; PROTEINS; SARCOPLASMIC RETICULUM;

MUS MUSCULUS; RODENTIA;

EID: 78650852025     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.021     Document Type: Review

References (75)

1. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998, 37:279-289.
2. Schmidt A.G., Edes I., Kranias E.G. Phospholamban: a promising therapeutic target in heart failure?. Cardiovasc Drugs Ther 2001, 15:387-396.
3. Watanabe H., Chopra N., Laver D., Hwang H.S., Davies S.S., Roach D.E., et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009, 15:380-383.
4. Hofmann S.L., Brown M.S., Lee E., Pathak R.K., Anderson R.G., Goldstein J.L. Purification of a sarcoplasmic reticulum protein that binds Ca2+ and plasma lipoproteins. J Biol Chem 1989, 264:8260-8270.
5. Arvanitis D.A., Vafiadaki E., Fan G.C., Mitton B.A., Gregory K.N., Del Monte F., et al. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol 2007, 293:H1581-H1589.
6. Gregory K.N., Ginsburg K.S., Bodi I., Hahn H., Marreez Y.M., Song Q., et al. Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function. J Mol Cell Cardiol 2006, 40:653-665.
7. Kim E., Shin D.W., Hong C.S., Jeong D., Kim D.H., Park W.J. Increased Ca2+ storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca2+ binding protein). Biochem Biophys Res Commun 2003, 300:192-196.
8. Lee H.G., Kang H., Kim D.H., Park W.J. Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J Biol Chem 2001, 276:39533-39538.
9. Sacchetto R., Damiani E., Turcato F., Nori A., Margreth A. Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region. Biochem Biophys Res Commun 2001, 289:1125-1134.
10. Campbell K.P., MacLennan D.H., Jorgensen A.O. Staining of the Ca2+-binding proteins, calsequestrin, calmodulin, troponin C, and S-100, with the cationic carbocyanine dye "Stains-all". J Biol Chem 1983, 258:11267-11273.
11. Damiani E., Margreth A. Subcellular fractionation to junctional sarcoplasmic reticulum and biochemical characterization of 170kDa Ca(2+)- and low-density-lipoprotein-binding protein in rabbit skeletal muscle. Biochem J 1991, 277(Pt 3):825-832.
12. Damiani E., Tarugi P., Calandra S., Margreth A. Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. Dev Biol 1992, 153:102-114.
13. Orr I., Shoshan-Barmatz V. Modulation of the skeletal muscle ryanodine receptor by endogenous phosphorylation of 160/150-kDa proteins of the sarcoplasmic reticulum. Biochim Biophys Acta 1996, 1283:80-88.
14. Picello E., Damiani E., Margreth A. Low-affinity Ca(2+)-binding sites versus Zn(2+)-binding sites in histidine-rich Ca(2+)-binding protein of skeletal muscle sarcoplasmic reticulum. Biochem Biophys Res Commun 1992, 186:659-667.
15. Shoshan-Barmatz V., Orr I., Weil S., Meyer H., Varsanyi M., Heilmeyer L.M. The identification of the phosphorylated 150/160-kDa proteins of sarcoplasmic reticulum, their kinase and their association with the ryanodine receptor. Biochim Biophys Acta 1996, 1283:89-100.
16. Sacchetto R., Turcato F., Damiani E., Margreth A. Interaction of triadin with histidine-rich Ca(2+)-binding protein at the triadic junction in skeletal muscle fibers. J Muscle Res Cell Motil 1999, 20:403-415.
17. Hojlund K., Bowen B.P., Hwang H., Flynn C.R., Madireddy L., Geetha T., et al. In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS. J Proteome Res 2009, 8:4954-4965.
18. Bousette N., Kislinger T., Fong V., Isserlin R., Hewel J.A., Emil A., et al. Large-scale characterization and analysis of the murine cardiac proteome. J Proteome Res 2009, 8:1887-1901.
19. Zhou X., Fan G.C., Ren X., Waggoner J.R., Gregory K.N., Chen G., et al. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury. Cardiovasc Res 2007, 75:487-497.
20. Fan G.C., Gregory K.N., Zhao W., Park W.J., Kranias E.G. Regulation of myocardial function by histidine-rich, calcium-binding protein. Am J Physiol Heart Circ Physiol 2004, 287:H1705-H1711.
21. Arvanitis D.A., Sanoudou D., Kolokathis F., Vafiadaki E., Papalouka V., Kontrogianni-Konstantopoulos A., et al. The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J 2008, 29:2514-2525.
22. Asimaki A., Syrris P., Wichter T., Matthias P., Saffitz J.E., McKenna W.J. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2007, 81:964-973.
23. Hofmann S.L., Topham M., Hsieh C.L., Francke U. cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum protein, and localization of the gene to human chromosome 19 and mouse chromosome 7. Genomics 1991, 9:656-669.
24. Brown S.D., Chartier F., Johnson K., Cavanna J.S. Mapping the Hrc gene to proximal mouse chromosome 7: delineation of a conserved linkage group with human 19q. Genomics 1993, 18:459-461.
25. Raeymaekers L., Verbist J., Wuytack F., Plessers L., Casteels R. Expression of Ca2+ binding proteins of the sarcoplasmic reticulum of striated muscle in the endoplasmic reticulum of pig smooth muscles. Cell Calcium 1993, 14:581-589.
26. Ridgeway A.G., Petropoulos H., Siu A., Ball J.K., Skerjanc I.S. Cloning, tissue distribution, subcellular localization and overexpression of murine histidine-rich Ca2+ binding protein. FEBS Lett 1999, 456:399-402.
27. Zarain-Herzberg A., MacLennan D.H., Periasamy M. Characterization of rabbit cardiac sarco(endo)plasmic reticulum Ca2(+)-ATPase gene. J Biol Chem 1990, 265:4670-4677.
28. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989, 339:439-445.
29. Ellis S.B., Williams M.E., Ways N.R., Brenner R., Sharp A.H., Leung A.T., et al. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science 1988, 241:1661-1664.
30. Korczak B., Zarain-Herzberg A., Brandl C.J., Ingles C.J., Green N.M., MacLennan D.H. Structure of the rabbit fast-twitch skeletal muscle Ca2+-ATPase gene. J Biol Chem 1988, 263:4813-4819.
31. Zarain-Herzberg A., Fliegel L., MacLennan D.H. Structure of the rabbit fast-twitch skeletal muscle calsequestrin gene. J Biol Chem 1988, 263:4807-4812.
32. Anderson J.P., Dodou E., Heidt A.B., De Val S.J., Jaehnig E.J., Greene S.B., et al. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol Cell Biol 2004, 24:3757-3768.
33. Guinamard R., Chatelier A., Demion M., Potreau D., Patri S., Rahmati M., et al. Functional characterization of a Ca(2+)-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol 2004, 558:75-83.
34. Kruse M., Schulze-Bahr E., Corfield V., Beckmann A., Stallmeyer B., Kurtbay G., et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 2009, 119:2737-2744.
35. Beranger F., Mejean C., Moniot B., Berta P., Vandromme M. Muscle differentiation is antagonized by SOX15, a new member of the SOX protein family. J Biol Chem 2000, 275:16103-16109.
36. Maruyama M., Ichisaka T., Nakagawa M., Yamanaka S. Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem 2005, 280:24371-24379.
37. Lee H.J., Goring W., Ochs M., Muhlfeld C., Steding G., Paprotta I., et al. Sox15 is required for skeletal muscle regeneration. Mol Cell Biol 2004, 24:8428-8436.
38. Hong S., Kim T.W., Choi I., Woo J.M., Oh J., Park W.J., et al. Complementary DNA cloning, genomic characterization and expression analysis of a mammalian gene encoding histidine-rich calcium binding protein. Biochim Biophys Acta 2005, 1727:188-196.
39. Wang S., Trumble W.R., Liao H., Wesson C.R., Dunker A.K., Kang C.H. Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998, 5:476-483.
40. Zhang L., Kelley J., Schmeisser G., Kobayashi Y.M., Jones L.R. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997, 272:23389-23397.
41. Nayler W.G., Anderson J.E. Effects of Zinc on Cardiac Muscle Contraction. Am J Physiol 1965, 209:17-21.
42. Suk J.Y., Kim Y.S., Park W.J. HRC (histidine-rich Ca2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem Biophys Res Commun 1999, 263:667-671.
43. Shannon T.R., Guo T., Bers D.M. Ca2+ scraps: local depletions of free [Ca2+] in cardiac sarcoplasmic reticulum during contractions leave substantial Ca2+ reserve. Circ Res 2003, 93:40-45.
44. Gyorke I., Hester N., Jones L.R., Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004, 86:2121-2128.
45. Guo W., Campbell K. Association of Triadin with the Ryanodine Receptor and Calsequestrin in the Lumen of the Sarcoplasmic Reticulum. J Biol Chem 1995, 270:9027-9030.
46. Toyoshima C., Mizutani T. Crystal structure of the calcium pump with a bound ATP analogue. Nature 2004, 430:529-535.
47. Toyoshima C., Nomura H., Tsuda T. Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues. Nature 2004, 432:361-368.
48. Dally S., Bredoux R., Corvazier E., Andersen J.P., Clausen J.D., Dode L., et al. Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c). Biochem J 2006, 395:249-258.
49. Kimura T., Nakamori M., Lueck J.D., Pouliquin P., Aoike F., Fujimura H., et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 2005, 14:2189-2200.
50. Lytton J., MacLennan D.H. Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+-ATPase gene. J Biol Chem 1988, 263:15024-15031.
51. Zarain-Herzberg A., Alvarez-Fernandez G. Sarco(endo)plasmic reticulum Ca2+-ATPase-2 gene: structure and transcriptional regulation of the human gene. ScientificWorldJournal 2002, 2:1469-1483.
52. Protonotarios N., Tsatsopoulou A., Patsourakos P., Alexopoulos D., Gezerlis P., Simitsis S., et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986, 56:321-326.
53. Rubenstein A., Merriam J., Klymkowsky M.W. Localizing the adhesive and signaling functions of plakoglobin. Dev Genet 1997, 20:91-102.
54. Green K.J., Gaudry C.A. Are desmosomes more than tethers for intermediate filaments?. Nat Rev Mol Cell Biol 2000, 1:208-216.
55. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007, 2:953-971.
56. Terentyev D., Viatchenko-Karpinski S., Gyorke I., Volpe P., Williams S.C., Gyorke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 2003, 100:11759-11764.
57. Viatchenko-Karpinski S., Terentyev D., Gyorke I., Terentyeva R., Volpe P., Priori S.G., et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004, 94:471-477.
58. Lahat H., Pras E., Eldar M. A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Ann Med 2004, 36(Suppl 1):87-91.
59. Eldar M., Pras E., Lahat H. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Cold Spring Harb Symp Quant Biol 2002, 67:333-337.
60. Eldar M., Pras E., Lahat H. A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med 2003, 13:148-151.
61. Lahat H., Pras E., Olender T., Avidan N., Ben-Asher E., Man O., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001, 69:1378-1384.
62. Song L., Alcalai R., Arad M., Wolf C.M., Toka O., Conner D.A., et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2007, 117:1814-1823.
63. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103:196-200.
64. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001, 103:485-490.
65. Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001, 10:189-194.
66. Sato Y., Ferguson D.G., Sako H., Dorn G.W., Kadambi V.J., Yatani A., et al. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 1998, 273:28470-28477.
67. Ji Y., Lalli M.J., Babu G.J., Xu Y., Kirkpatrick D.L., Liu L.H., et al. Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function. J Biol Chem 2000, 275:38073-38080.
68. Periasamy M., Reed T.D., Liu L.H., Ji Y., Loukianov E., Paul R.J., et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem 1999, 274:2556-2562.
69. Dash R., Frank K.F., Carr A.N., Moravec C.S., Kranias E.G. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol 2001, 33:1345-1353.
70. Jaehnig E.J., Heidt A.B., Greene S.B., Cornelissen I., Black B.L. Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein. Mol Cell Biol 2006, 26:9315-9326.
71. Morgan J.P., Erny R.E., Allen P.D., Grossman W., Gwathmey J.K. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990, 81:III21-III32.
72. Gupta R.C., Mishra S., Rastogi S., Wang M., Rousso B., Mika Y., et al. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. Clin Transl Sci 2009, 2:211-215.
73. van den Broek F.A., Bakker R., den Bieman M., Fielmich-Bouwman A.X., Lemmens A.G., van Lith H.A., et al. Genetic analysis of dystrophic cardiac calcification in DBA/2 mice. Biochem Biophys Res Commun 1998, 253:204-208.
74. de Meeus A., Stephan E., Debrus S., Jean M.K., Loiselet J., Weissenbach J., et al. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res 1995, 77:735-740.
75. Brink P.A., Ferreira A., Moolman J.C., Weymar H.W., van der Merwe P.L., Corfield V.A. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 1995, 91:1633-1640.